A synthetic tetrapeptide derived from a pineal-gland peptide, studied for telomerase activity and circadian signaling.
Coming soon
You are on the list. We will email you when Epithalon becomes available — and nothing else. Joining is not a medical request, and no prescription has been issued.
That did not go through. Check the address and try again.
Epithalon is coming soon to Promise. Add your email and we'll let you know when visits open.
A licensed provider reviews every request; not everyone qualifies.
Every treatment gets its own online clinical questionnaire — your history, medications, and goals.
A real person goes through your history and takes the time to get it right before anything is decided.
If a treatment isn't right for your history, you'll hear that plainly. That review is the whole point.
Made for your prescription by a licensed U.S. pharmacy and shipped in temperature-safe packaging.
Your care team checks in after it arrives. Adjust with your provider, or cancel at any time.
Epithalon will be offered as an injectable. Your provider decides whether it's appropriate — including whether a different treatment would serve you better.
10 mg/mL × 5 mL vial (50 mg)
Epithalon is easy to find online and hard to trust there. Promise works the way medicine is supposed to work — a clinician decides, a licensed pharmacy fills, and someone stays accountable to you.
Prescribed for you specifically, after a real look at your health history — never pulled off a shelf.
Your prescription is compounded for you by a licensed U.S. pharmacy — not a mystery vial from an unregulated website.
Temperature-safe shipping, follow-up check-ins, and a care team that answers — before and after your medication arrives.
Epithalon is a synthetic tetrapeptide derived from epithalamin, a pineal-gland extract. Research interest centers on telomerase activity and on circadian and pineal signaling.
Once visits open, it renews every 28 days until you cancel; the prescribing provider sets the protocol and stays involved through follow-up check-ins.
A licensed provider reads your history, decides whether Epithalon fits it, and sets the protocol.
Epithalon is one of the older ideas in longevity research and one of the least settled. It is a synthetic peptide of four amino acids, derived from a pineal-gland extract, and it is studied for its effect on telomerase and on the pineal signaling that governs circadian rhythm.
It is coming soon to Promise as an injectable — add me to the list. A licensed provider reviews your health history and prescribes only when treatment is appropriate for you.
Epithalon is a tetrapeptide — alanine, glutamic acid, aspartic acid, glycine — synthesized as a simplified version of epithalamin, an extract taken from the pineal gland. The pineal gland is the small structure that produces melatonin and helps set the body's day-night timing, and the original research programme was built around the idea that peptides from that gland influence how the system ages.
It belongs to our anti-aging and longevity category alongside GHK-Cu, though the two come at the subject from completely different directions. GHK-Cu is studied in connective tissue and copper transport; Epithalon is studied at the level of cellular replication and biological timing.
The laboratory case is coherent. Cell and animal studies have examined Epithalon's influence on telomerase, the enzyme that maintains the protective caps on the ends of chromosomes, and on markers tied to pineal and circadian function. That is a real, describable mechanism, and it is why the compound keeps resurfacing in longevity discussion.
The human case is thin, and we would rather say so than imply otherwise. Most clinical work on Epithalon comes from a small number of studies run in Russia over several decades, much of it published in Russian, with small participant groups and limited independent replication. Nothing here is settled science. A described mechanism is not an outcome, and interest in a compound is not evidence about it.
Once visits open, Epithalon is prescribed as a recurring plan: after the first shipment, it renews every 28 days until you cancel. The provider who evaluates you sets the protocol; this page does not publish a schedule.
Follow-up check-ins keep that provider involved, and the protocol can be reviewed, adjusted or stopped there.
Everything starts with an intake questionnaire built specifically for this compound: your health history, current medications, and what you are trying to address. A licensed provider reads it. If Epithalon is a reasonable fit for your history, they write the prescription and set the protocol. If it is not, they decline, and they will say so.
Given how limited the human evidence is, that gate carries more weight here than usual. A provider weighing Epithalon is weighing a thin clinical file against your particular chart, and for many people the reasonable answer is a different compound or none at all.
If you are prescribed, your medication is compounded and dispensed by a licensed U.S. pharmacy, and shipped in discreet, temperature-safe packaging. Dosing is not a number to find online; your provider sets the protocol from your evaluation, and you follow theirs.
Your care team checks in along the way. The plan renews every 28 days until you cancel, and any change to the protocol goes through your provider. Epithalon sits on top of the fundamentals, particularly sleep, rather than standing in for them. It is a support for the promise you already made to yourself, not a replacement for the work.
Epithalon is a synthetic peptide of four amino acids — alanine, glutamic acid, aspartic acid, and glycine. It was derived from epithalamin, an extract of the pineal gland, and research interest centers on telomerase activity and on the pineal gland's role in circadian rhythm. It is coming soon to Promise.
A real prescription. Epithalon is coming soon to Promise, and when visits open, a licensed provider will review your history before deciding whether to prescribe it; if it is prescribed, a licensed U.S. pharmacy will compound the medication for you. It will not be a product labeled for laboratory use.
No. A licensed provider reviews every Epithalon request and prescribes only when it is appropriate for you. If it isn't, you'll be told plainly — that review is the point.
Epithalon is coming soon to Promise. Once visits open, like every Promise treatment it is prescribed as a recurring plan: after the first shipment, it renews every 28 days until you cancel. Your provider sets the protocol after reviewing your history, and follow-up check-ins are where it is reviewed, adjusted or stopped.
Yes. Epithalon is prescription-only, and it is coming soon to Promise. Once visits open, you complete an intake questionnaire, a licensed provider reviews your health history, and they prescribe only when treatment is appropriate for you.
No. Epithalon is not FDA-approved. It is coming soon to Promise as a compounded medication, and compounded medications are not reviewed by the FDA for safety, effectiveness, or quality. When visits open, it will be prepared by a licensed U.S. compounding pharmacy against a prescription written for you specifically, after a licensed provider has reviewed your health history.
Weaker than the conversation around it suggests, and it is worth saying so plainly. Most of the human work comes from a small number of studies conducted in Russia over several decades, much of it published in Russian, with small groups and methods that have not been widely replicated elsewhere. The laboratory and animal work on telomerase and pineal signaling is more consistent, but it does not tell you what happens in a person. Epithalon is a compound with an interesting mechanism and a thin clinical file, which is exactly why the decision belongs to a clinician who knows your history.
Epithalon sold online without a prescription is usually labeled for laboratory use, with no provider, no pharmacy, and no one accountable if something goes wrong. Promise works the way medicine is supposed to: a licensed provider decides, a licensed U.S. pharmacy compounds your prescription, and a care team follows up.
Other Anti-Aging & Longevity options a provider may consider.
Muscle & Recovery
Four-peptide blend — BPC-157, GHK-Cu, KPV, TB-500 — studied for tissue repair, skin, and recovery support.
Requires an online medical evaluation. Prescribed only when a licensed provider determines it's appropriate.
Anti-Aging & Longevity
A naturally occurring copper-binding tripeptide studied for skin remodeling and collagen-synthesis signaling, and one of the peptides in our KLOW blend.
Requires an online medical evaluation. Prescribed only when a licensed provider determines it's appropriate.
The latest from the Promise team on Epithalon.
Epitalon's cell findings are real. They don't establish longer human life, better sleep, a yearly treatment schedule or freedom from side effects.
July brought favorable advisory votes and a new cancer-cell study. Here is what changed for epitalon, what the FDA’s current pages say, and what remains unproven in people.
Epitalon has been studied for melatonin production, but better sleep hasn't been demonstrated in people. The small human study measured a hormone marker.
Type a treatment, a goal, or a question.